Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Assessment of Serum Macrophage Migration Inhibitory Factor (MIF) as an Early Diagnostic Marker of Leptospirosis

View through CrossRef
The search for valuable early diagnostic markers for leptospirosis is ongoing. The aim of the present study was to evaluate the diagnostic value of macrophage migration inhibitory factor (MIF) for leptospirosis. MIF is an immunoregulatory cytokine secreted by a variety of cell types involved in immune response and the pathogenesis of various diseases. It was previously described as a severity predictor of diseases. Samples of 142 leptospirosis cases, 101 other febrile cases, and 57 healthy controls were studied. The prevalence of leptospirosis was 47.3%. Autumnalis, Australis, and Canicola were the highly prevalent leptospiral serovars with a microscopic agglutination test (MAT) titer in the range 1:80–1:2,560. Enzyme-linked immunosorbent assay (ELISA) of MIF was carried out to measure the serum MIF levels. We found that the serum MIF levels [median, (interquartile range)] were significantly (p < 0.001) elevated in different clinical forms of leptospirosis, such as febrile illness [7.5 ng/ml (5.32–8.97)], pulmonary hemorrhage [13.2 ng/ml (11.77–16.72)], Weil’s syndrome [8.8 ng/ml (7.25–9.95)], and renal failure [8.6 ng/ml (7.18–10.5)], than in healthy controls [0.65n g/ml (0.5–1.1)]. Serum MIF had sensitivity, specificity, positive predictive value, and negative predictive value of 100%, >90%, >90%, and 100%, respectively. Receiver operating characteristic (ROC) analysis revealed that the serum MIF levels between leptospirosis cases and control subjects had an area under the curve (AUC) value of >0.9 (p < 0.0001). In leptospirosis patients, elevation of serum MIF was significantly (p < 0.001) higher in severe cases with organ dysfunction [10 ng/ml (7.8–14.5)] than that in mild febrile cases [7.5 ng/ml (5.32–8.97)], with the difference of 2.5 indicating that serum MIF acts as a predictor of leptospirosis severity. Pearson’s correlation test demonstrated that the serum MIF level was strongly correlated (r = 0.75, p < 0.0001) with disease progression. The median lethal dose (LD50) of leptospiral lipopolysaccharide (LPS) in BALB/c mice was determined to be 20 mg/kg, which gave rise to endotoxemia. Leptospiral LPS triggered the upregulation of MIF expression at 24 h post-infection, which reached the peak level at 24 h post-treatment in THP-1 cells and showed elevated MIF expressions in different tissues of BALB/c mice at the early stage of infection. Taken together, MIF is an early-phase cytokine that could serve as a rapid diagnostic marker for leptospirosis.
Title: Assessment of Serum Macrophage Migration Inhibitory Factor (MIF) as an Early Diagnostic Marker of Leptospirosis
Description:
The search for valuable early diagnostic markers for leptospirosis is ongoing.
The aim of the present study was to evaluate the diagnostic value of macrophage migration inhibitory factor (MIF) for leptospirosis.
MIF is an immunoregulatory cytokine secreted by a variety of cell types involved in immune response and the pathogenesis of various diseases.
It was previously described as a severity predictor of diseases.
Samples of 142 leptospirosis cases, 101 other febrile cases, and 57 healthy controls were studied.
The prevalence of leptospirosis was 47.
3%.
Autumnalis, Australis, and Canicola were the highly prevalent leptospiral serovars with a microscopic agglutination test (MAT) titer in the range 1:80–1:2,560.
Enzyme-linked immunosorbent assay (ELISA) of MIF was carried out to measure the serum MIF levels.
We found that the serum MIF levels [median, (interquartile range)] were significantly (p < 0.
001) elevated in different clinical forms of leptospirosis, such as febrile illness [7.
5 ng/ml (5.
32–8.
97)], pulmonary hemorrhage [13.
2 ng/ml (11.
77–16.
72)], Weil’s syndrome [8.
8 ng/ml (7.
25–9.
95)], and renal failure [8.
6 ng/ml (7.
18–10.
5)], than in healthy controls [0.
65n g/ml (0.
5–1.
1)].
Serum MIF had sensitivity, specificity, positive predictive value, and negative predictive value of 100%, >90%, >90%, and 100%, respectively.
Receiver operating characteristic (ROC) analysis revealed that the serum MIF levels between leptospirosis cases and control subjects had an area under the curve (AUC) value of >0.
9 (p < 0.
0001).
In leptospirosis patients, elevation of serum MIF was significantly (p < 0.
001) higher in severe cases with organ dysfunction [10 ng/ml (7.
8–14.
5)] than that in mild febrile cases [7.
5 ng/ml (5.
32–8.
97)], with the difference of 2.
5 indicating that serum MIF acts as a predictor of leptospirosis severity.
Pearson’s correlation test demonstrated that the serum MIF level was strongly correlated (r = 0.
75, p < 0.
0001) with disease progression.
The median lethal dose (LD50) of leptospiral lipopolysaccharide (LPS) in BALB/c mice was determined to be 20 mg/kg, which gave rise to endotoxemia.
Leptospiral LPS triggered the upregulation of MIF expression at 24 h post-infection, which reached the peak level at 24 h post-treatment in THP-1 cells and showed elevated MIF expressions in different tissues of BALB/c mice at the early stage of infection.
Taken together, MIF is an early-phase cytokine that could serve as a rapid diagnostic marker for leptospirosis.

Related Results

The Role of Macrophage Migration Inhibitory Factor (MIF) in Regulation of T-Cell Activity in Multiple Myeloma
The Role of Macrophage Migration Inhibitory Factor (MIF) in Regulation of T-Cell Activity in Multiple Myeloma
Background: Multiple myeloma (MM) is the second most common hematological malignancy associated with the overproduction of light chain or monoclonal immunoglobulin. MM remains incu...
Macrophage migration inhibition factor in peripheral blood and induced sputum in patients with COPD
Macrophage migration inhibition factor in peripheral blood and induced sputum in patients with COPD
BACKGROUND : Macrophage migration inhibition factor (MIF) induce many inflammatory mediators that involved in the pathogenesis of COPD, we reason that MIF may c...
Serum macrophage migration‐inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer
Serum macrophage migration‐inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer
AbstractBACKGROUND:This study aimed to determine the potential diagnostic value of migration‐inhibitory factor (MIF) for gastric cancer in patients presenting with dyspepsia and it...
How do alarmins affect Th9 cell differentiation?
How do alarmins affect Th9 cell differentiation?
Effet des alarmines dans la différentiation de cellules Th9 Les cellules T jouent un rôle central dans l'immunité anticancéreuse. Outre les cellules T CD8 cytotoxiq...
1598-P: MIF-upregulated CD74 in Liver Contributes to the Development of NAFLD
1598-P: MIF-upregulated CD74 in Liver Contributes to the Development of NAFLD
Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic dysfunctions, such as obesity. Macrophage migration inhibitory factor (MIF), a pro-cytokine, was also identifi...
Macrophage Migration Inhibitory Factor Promotes Tumor Invasion and Metastasis via the Rho-Dependent Pathway
Macrophage Migration Inhibitory Factor Promotes Tumor Invasion and Metastasis via the Rho-Dependent Pathway
Abstract Purpose: Macrophage migration inhibitory factor (MIF) plays an important role not only in the immune system but also in tumorigenesis. In this study, we inv...

Back to Top